Cargando…
Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy
OBJECTIVE: To describe the neuropathologic features and the molecular data of phosphorylated tau (pTau) in a new case of anti-IgLON5 disease. METHODS: Review of clinical data, postmortem neuropathologic examination. Biochemical analyses of pTau were performed in brain samples from the present case a...
Autores principales: | Erro, Maria Elena, Sabater, Lidia, Martínez, Laura, Herrera, María, Ostolaza, Aiora, García de Gurtubay, Iñaki, Tuñón, Teresa, Graus, Francesc, Gelpi, Ellen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007636/ https://www.ncbi.nlm.nih.gov/pubmed/31826985 http://dx.doi.org/10.1212/NXI.0000000000000651 |
Ejemplares similares
-
Neuropathological criteria of anti-IgLON5-related tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2016) -
Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016) -
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)